New Antibacterials Against D,D- and L,D-Transpeptidases
Report of Invention:
10/5/2016
Unmet needb-lactam antibacterial agents target peptidoglycan biosynthesis and are used for treatment of infection, but have been ineffective in treatment of Tuberculosis (TB). This lack of activity has been attributed to the presence of b-lactamase and limited penetration of the thick mycolate coat. Thus, new generation of antibacterial agents to treat TB, a disease that causes more deaths worldwide than any other infectious disease, are urgently needed. Technology overviewJohns Hopkins researchers have identified novel b-lactam antibacterials that contain a bicyclic penem core. The current antibacterials are poor substrates for β-lactamases, and can also inhibit non-classical transpeptidases, l,d-transpeptidases, that generate the majority of linkages in the peptidoglycan of mycobacteria. They verified that these compounds bind l,d-transpeptidases of several bacterial pathogens, using kinetics and x-ray structural studies. The pathogens include Gram-positive, Gram-negative and acid-fast bacteria. Stage of developmentDiscovery PublicationsKumar P et al. Nat Chem Biol 13(1), 54–61, 2017
Patent Information:
Title |
App Type |
Country |
Serial No. |
Patent No. |
File Date |
Issued Date |
Expire Date |
Patent Status |
ANTIBACTERIAL AGENTS AGAINST D,D- AND L,D-TRANSPEPTIDASES |
PCT: Patent Cooperation Treaty |
European Patent Office |
17859990.8 |
3523309 |
10/10/2017 |
4/17/2024 |
10/10/2037 |
Granted |
ANTIBACTERIAL AGENTS AGAINST D,D- AND L,D-TRANSPEPTIDASES |
PCT: Patent Cooperation Treaty |
France |
17859990.8 |
3523309 |
10/10/2017 |
4/17/2024 |
10/10/2037 |
Granted |
ANTIBACTERIAL AGENTS AGAINST D,D- AND L,D-TRANSPEPTIDASES |
PCT: Patent Cooperation Treaty |
Germany |
17859990.8 |
3523309 |
10/10/2017 |
4/17/2024 |
10/10/2037 |
Granted |
ANTIBACTERIAL AGENTS AGAINST D,D- AND L,D-TRANSPEPTIDASES |
PCT: Patent Cooperation Treaty |
United Kingdom |
17859990.8 |
3523309 |
10/10/2017 |
4/17/2024 |
10/10/2037 |
Granted |
ANTIBACTERIAL AGENTS AGAINST D,D- AND L,D-TRANSPEPTIDASES |
PCT: Patent Cooperation Treaty |
United States |
16/340,244 |
11,084,833 |
4/8/2019 |
8/10/2021 |
1/15/2038 |
Granted |
|
|
Inventors:
Category(s):
Clinical and Disease Specializations, Technology Classifications > Therapeutic Modalities > Small Molecules, Clinical and Disease Specializations > Infectious Diseases, Technology Classifications > Therapeutic Modalities, Clinical and Disease Specializations > Infectious Diseases > Bacterial Infections,
Get custom alerts for techs in these categories/from these inventors:
|